Purchases and Sales Made in Q1 2024 in Xtl Biopharmaceuticals LTD (XTLB)
This table provides information about the institutional ownership of Xtl Biopharmaceuticals LTD (XTLB) during Q1 2024. The information is specifically focused on institutions that hold shares of XTL BIOPHARMACEUTICALS LTD.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 15, 2024
Q1 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
- |
13.6KNew |
$10.9K - $41.8K
|
13.6K
$21.9K
|
|
|
May 13, 2024
Q1 2024
|
Ubs Group Ag
|
BUY
|
- |
6.9K+ 12777.78% |
$5.52K - $21.2K
|
6.95K
$11.2K
|
|
|
Oct 17, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
BUY
|
- |
6.02K+ 18.16% |
$4.82K - $18.5K
|
39.2K
$63.1K
|
|
|
Apr 30, 2024
Q1 2024
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
May 15, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-600- 1.51% |
$480 - $1.84K
|
39.2K
$63.1K
|
|
|
Aug 16, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-600- 1.51% |
$480 - $1.84K
|
39.2K
$63.1K
|